Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Telemedycyna PolskaWAR:TMP 31 Debt-to-Equity is 6.03 as of Mar. 2026, which is 2219% above its 10-year median of 0.26. GuruFocus rates WAR:TMP with a GF Score™ of 31/100 and a GF Value™ of zł0.80 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 560 Healthcare Providers & Services companies, Telemedycyna Polska ranks worse than 98.04% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Telemedycyna Polska's Debt-to-Equity or its related term are showing as below:
WAR:TMP'
s Debt-to-Equity Range Over the Past 10 Years
Min: -9.08 Med: 0.26 Max: 6.03
Current: 6.03
During the past 13 years, the highest Debt-to-Equity Ratio of Telemedycyna Polska was 6.03. The lowest was -9.08. And the median was 0.26.
WAR:TMP's Debt-to-Equity is ranked worse than 98.04% of 560
companies
in the Healthcare Providers & Services industry
Industry Median: 0.42
vs WAR:TMP: 6.03
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Telemedycyna Polska Debt-to-Equity Related Terms
Telemedycyna Polska Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Telemedycyna Polska's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:TMP vs VEEV, BTSG, HQY: Debt-to-Equity Comparison
For the Health Information Services subindustry, Telemedycyna Polska's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Telemedycyna Polska Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Telemedycyna Polska's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Telemedycyna Polska's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Telemedycyna Polska (WAR:TMP) has a Debt-to-Equity of 6.03 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Telemedycyna Polska and its competitors. This is 2219% above median its historical median of 0.26. According to the industry distribution chart, Telemedycyna Polska ranks #549 out of 560 companies in the Healthcare Providers & Services industry, placing it in the top 98%.
Is Telemedycyna Polska's Debt-to-Equity too high?
Telemedycyna Polska's current Debt-to-Equity of 6.03 is 2219% above median its 10-year median of 0.26. The Healthcare Providers & Services industry median Debt-to-Equity is 0.42. Telemedycyna Polska's value of 6.03 is 1335.7% above this industry median. Based on the distribution chart, Telemedycyna Polska ranks #549 out of 560 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Telemedycyna Polska has a GF Score™ of 31/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Telemedycyna Polska's Debt-to-Equity compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Telemedycyna Polska ranks #549 out of 560 companies for Debt-to-Equity. This places Telemedycyna Polska in the lower half of its industry. The industry median Debt-to-Equity is 0.42. Telemedycyna Polska's value of 6.03 is 1335.7% above this benchmark. While the company's 10-year median is 0.26 vs. the industry median of 0.42, Telemedycyna Polska has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.42, based on 560 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Telemedycyna Polska's current Debt-to-Equity of 6.03 is 1335.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Telemedycyna Polska and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Telemedycyna Polska's current Debt-to-Equity is 6.03, which is 2219% above median its own 10-year median of 0.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Telemedycyna Polska stock overvalued right now?
Based on GuruFocus' analysis, Telemedycyna Polska (WAR:TMP) is currently considered Modestly Undervalued. The stock's GF Value™ is zł0.80, compared to a current price of zł0.61 — trading 23.8% below its estimated fair value. The current Debt-to-Equity is 6.03, which is 2219% above median its 10-year median of 0.26 and 1335.7% above the Healthcare Providers & Services industry median of 0.42. Telemedycyna Polska's overall GF Score™ is 31/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Telemedycyna Polska (WAR:TMP), the current Debt-to-Equity is 6.03 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Telemedycyna Polska (WAR:TMP) Overvalued in 2026?
Based on GuruFocus' analysis, Telemedycyna Polska stock appears to be undervalued.
The current stock price of zł0.61 is trading 23.8% below its estimated GF Value™ of zł0.80.
GuruFocus considers Telemedycyna Polska to be Modestly Undervalued.
Key valuation signals for WAR:TMP:
Debt-to-Equity: 6.03 (2219% above median its 10-year median of 0.26)
GF Value™: zł0.80 vs. price of zł0.61 (23.8% below fair value)
Industry Position: 1335.7% above the Healthcare Providers & Services median (#549 of 560)
No single metric tells the full story. See the WAR:TMP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Telemedycyna Polska SA offers telecardiology services for individual patients and medical facilities in Poland. The company offers cardiologic care services through telephone and Internet. The company also provides telemedical services to health centres.
31GF Score
Get the complete analysis for WAR:TMP
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:TMP has been successfully added to your 
